Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1995 1
2002 2
2005 1
2012 2
2013 1
2015 1
2016 1
2018 1
2019 1
2020 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Predicting survival of advanced laryngeal squamous cell carcinoma: comparison of machine learning models and Cox regression models.
Zhang YF, Shen YJ, Huang Q, Wu CP, Zhou L, Ren HL. Zhang YF, et al. Sci Rep. 2023 Oct 28;13(1):18498. doi: 10.1038/s41598-023-45831-8. Sci Rep. 2023. PMID: 37898687 Free PMC article.
The ROC curve revealed that the Cox model exhibited good sensitivity and specificity in predicting DFS in the training and validation cohorts (1 year, validation AUC = 0.679, training AUC = 0.693; 3 years, validation AUC = 0.716, training AUC = 0.655; 5 years, validation AUC = 0. …
The ROC curve revealed that the Cox model exhibited good sensitivity and specificity in predicting DFS in the training and validation cohort …
Neoadjuvant therapy in cancer treatment.
Trimble EL, Ungerleider RS, Abrams JA, Kaplan RS, Feigal EG, Smith MA, Carter CL, Friedman MA. Trimble EL, et al. Cancer. 1993 Dec 1;72(11 Suppl):3515-24. doi: 10.1002/1097-0142(19931201)72:11+<3515::aid-cncr2820721619>3.0.co;2-a. Cancer. 1993. PMID: 8242583 Review.
Response to chemotherapy, ascertained by histologic review of the surgical specimen, can be used to tailor postoperative chemotherapy. In patients with advanced laryngeal squamous cell carcinoma, neoadjuvant chemotherapy followed by radiation ha …
Response to chemotherapy, ascertained by histologic review of the surgical specimen, can be used to tailor postoperative chemotherapy. In pa …
From VA Larynx to the future of chemoselection: Defining the role of induction chemotherapy in larynx cancer.
Spector ME, Rosko AJ, Swiecicki PL, Chad Brenner J, Birkeland AC. Spector ME, et al. Oral Oncol. 2018 Nov;86:200-205. doi: 10.1016/j.oraloncology.2018.09.026. Epub 2018 Oct 1. Oral Oncol. 2018. PMID: 30409302 Review.
Organ preservation protocols utilizing induction chemotherapy as a selection agent have played a critical role in the treatment of advanced laryngeal squamous cell carcinoma (LSCC). The selection of patients who will have a good response to chem …
Organ preservation protocols utilizing induction chemotherapy as a selection agent have played a critical role in the treatment of advanc …
A Study of Peripheral Blood Parameters to Predict Response to Induction Chemotherapy and Overall Survival in Advanced Laryngeal Squamous Cell Carcinoma.
Xu J, Yang Y, Zhong Q, Hou L, Ma H, Zhang Y, Feng L, He S, Lian M, Fang J, Wang R. Xu J, et al. Curr Oncol. 2022 Sep 9;29(9):6472-6484. doi: 10.3390/curroncol29090509. Curr Oncol. 2022. PMID: 36135078 Free PMC article.
PURPOSE: the purpose of this study was to screen peripheral blood parameters and construct models predicting the prognosis and induction chemotherapy (IC) response in locally advanced laryngeal squamous cell carcinoma (LSCC) patients. METHODS: A …
PURPOSE: the purpose of this study was to screen peripheral blood parameters and construct models predicting the prognosis and induction che …
Eosinophilic infiltration in advanced laryngeal squamous cell carcinoma. Veterans Administration Laryngeal Cooperative Study Group.
Sassler AM, McClatchey KD, Wolf GT, Fisher SG. Sassler AM, et al. Laryngoscope. 1995 Apr;105(4 Pt 1):413-6. doi: 10.1288/00005537-199504000-00014. Laryngoscope. 1995. PMID: 7715387 Clinical Trial.
Contrary to the findings of earlier preliminary reports, our results suggest that TATE is not a clinical useful prognostic parameter in advanced laryngeal squamous cell carcinoma....
Contrary to the findings of earlier preliminary reports, our results suggest that TATE is not a clinical useful prognostic parameter …
The oncologic radicality of supracricoid partial laryngectomy with cricohyoidopexy in the treatment of advanced N0-N1 laryngeal squamous cell carcinoma.
De Virgilio A, Fusconi M, Gallo A, Greco A, Kim SH, Conte M, Alessi S, Tombolini M, de Vincentiis M. De Virgilio A, et al. Laryngoscope. 2012 Apr;122(4):826-33. doi: 10.1002/lary.23178. Epub 2012 Feb 16. Laryngoscope. 2012. PMID: 22344785 Clinical Trial.
Local and locoregional control in the two treatment groups were overlapping, showing that cricohyoidopexy (when technically feasible) could be a valid surgical option in selected advanced laryngeal squamous cell carcinoma....
Local and locoregional control in the two treatment groups were overlapping, showing that cricohyoidopexy (when technically feasible) could …
Elective transcervical superior mediastinal lymph node dissection for advanced laryngeal and level 4 N3 squamous cell carcinoma.
Oxford LE, Ducic Y. Oxford LE, et al. Laryngoscope. 2005 Apr;115(4):625-8. doi: 10.1097/01.mlg.0000161336.69762.5d. Laryngoscope. 2005. PMID: 15805871
OBJECTIVES: To review our results with elective superior mediastinal lymph node dissections in patients with advanced laryngeal squamous cell carcinoma (SCCA) and overt level 4 adenopathy. ...
OBJECTIVES: To review our results with elective superior mediastinal lymph node dissections in patients with advanced laryngeal …
Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation.
Trask DK, Wolf GT, Bradford CR, Fisher SG, Devaney K, Johnson M, Singleton T, Wicha M. Trask DK, et al. Laryngoscope. 2002 Apr;112(4):638-44. doi: 10.1097/00005537-200204000-00009. Laryngoscope. 2002. PMID: 12150516
STUDY DESIGN: Retrospective analysis of immunohistochemical tumor characteristics and clinical outcome. METHODS: To determine whether Bcl-2 family proteins were predictive of successful organ preservation, immunohistochemical analysis of tissue specimens from 47 patients w …
STUDY DESIGN: Retrospective analysis of immunohistochemical tumor characteristics and clinical outcome. METHODS: To determine whether …
Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma.
Teknos TN, Cox C, Yoo S, Chepeha DB, Wolf GT, Bradford CR, Carey TE, Fisher SG. Teknos TN, et al. Head Neck. 2002 Nov;24(11):1004-11. doi: 10.1002/hed.10163. Head Neck. 2002. PMID: 12410536 Free article.
PURPOSE: The purpose of this study was to determine whether serum vascular endothelial growth factor (s-VEGF) levels at the time of diagnosis correlate with any known tumor variables and overall survival in patients with advanced laryngeal squamous cell …
PURPOSE: The purpose of this study was to determine whether serum vascular endothelial growth factor (s-VEGF) levels at the time of diagnosi …
14 results